Slumber Sleep Inc. Condemns Federal Move to Ban Hemp-Derived Products; Urges Congress to Pursue Science-Based Regulation, Not Blanket Prohibition

Slumber Sleep Inc., a leading maker of rigorously tested, hemp-derived sleep products, today issued a forceful objection to last-minute federal spending bill language that would effectively recriminalize most hemp-derived cannabinoids. The provision—passed in Congress this week—would redefine legal hemp and impose near-zero THC thresholds, sweeping in non-intoxicating products and destabilizing a sector relied on by millions of Americans for relief, including more than 200,000 Slumber customers who use the brand’s products for ongoing sleep support.

“This is a blunt instrument that punishes companies that have done everything right,” said Alec Tremaine, Chief Revenue Officer of Slumber Sleep Inc. “For years, we’ve invested in third-party testing, transparent labels, small-batch manufacturing, and consumer research – all to help people find natural alternatives to sleep issues and disorders. Congress should be targeting bad actors and unsafe products, not dismantling legitimate, science-backed brands that have helped over 200,000 Americans sleep better.”

Real-World Stakes for Sleepless Americans

Slumber’s customers are predominantly adults who have struggled with sleeplessness for a year or longer, according to 5,000+ survey responses. Many relied on prescription medications with debilitating side effects before finding relief with carefully formulated hemp products from Slumber. A broad federal ban yanks away proven options credited in sleep studies with reducing sleep awakenings, improving sleep duration by 72 minutes per night, and increasing quality of sleep, according to real Slumber customers.

Slumber’s Consumer-First Safeguards

• Full third-party lab testing for all raw materials and finished products, with published results to verify identity, purity, and advertised cannabinoid content.
• Small-batch production with ingredient vetting, supplier audits, and retention samples for traceability.
• Consumer research program (surveys and sleep-tracking pilots) to continuously improve efficacy and safety profiles.

A Better Pathway: Regulate, Don’t Prohibit

Slumber calls on Congress to replace prohibition with a modern, science-based regulatory framework that:

1. Sets adult-use age gates and restricts youth-appealing marketing;
2. Mandates accredited lab testing (identity, potency, contaminants, solvents, heavy metals);
3. Requires clear labeling (total THC, CBD, other cannabinoids; serving sizes; warnings);
4. Enforces retail channel standards (licensed sellers only);
5. Creates recall and adverse-event reporting and stiff penalties for fraud or adulteration.

This targeted approach directly addresses the “bad actor” problem lawmakers cite—without criminalizing responsible companies or depriving consumers of safe, effective alternatives. Recent reporting underscores that the language would ban products with more than ~0.4 mg total THC per container—a limit so low that it would capture non-intoxicating, full-spectrum offerings alongside intoxicating items, while industry and even some Republican lawmakers have raised alarm over the scope and tactics of the provision.

“We stand ready to help Congress write the rules,” Alec Tremaine added. “Require verified testing. Require age gating. Require truthful labels. Punish counterfeits and synthetics that harm consumers. But don’t erase an entire category that helps Americans sleep and quality of life.”

What’s Happening in Congress

The Senate advanced a shutdown-ending spending package containing hemp restrictions after rejecting an amendment to remove the ban; attention now turns to the House amid visible Republican unease over the hemp language and its consequences for farmers, manufacturers, and consumers.